ReviewCancers2022

Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma.

Marcus T T Roalsø et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.